Chalcones are useful intermediates in the synthesis of heterocyclic compound and the unique reagents in organic synthesis. The usual approach to obtain chalcones is through Claisen-Schmidt condensation. Several novel heterocyclic chalcone analogs have emerged. Chalcones are multifunctional molecules that possess promising pharmacological activities. Chalcones are known for anti-cancer, antioxidant, anti-inflammatory, anti-microbial, anti-tubercular, antileishmanial, antimalarial, anthelmintic, osteogenic activities. This review article focuses on recent applications of Claisen-Schmidt condensation reaction employed in the synthesis of chalcone, its transformation to heterocyclic compounds and pharmacological activities.
INTRODUCTION
Chalcones, unsaturated aromatic ketones are natural products, group of biaryl propenones of C6-C3-C6 precursors. 1,3-Diphenyl-2-propene-1one is the main pharmacophore and benzylideneacetophenone as a parent member of chalcones ( Fig. 1 ). They are electrophile (Michael acceptor) with three reactive carbons (α,β-unsaturated ketone) and a diverse array of substituents that cause both carbons to be readily attacked by nucleophiles. They contain conjugated double bonds with a completely delocalized π electron system on the structure which enables them to undergo electron transfer reactions. Chalcones transformation might proceed either by 1,4-addition or 1,2-addition. Examples of heterocyclic compounds from chalcones are pyrazoles [1, 2] , pyrroles [3] [4] [5] , pyrazoline [6] , isoxazoles [7] [8] [9] , pyrimidines [10, 11] , pyridines [12] [13] [14] [15] [16] , indoles, indazoles, triazoles [17, 18] , imidazoles [19, 20] , thiazines [21] , 1,5-benzodiazepines, 1,3,4-thiadiazepines, benzoazepines, and 1,5-benzodiazepines [22] . Chalcones are multifunctional molecules that possess promising pharmacological activities. Chalcones have been found useful as anticancer [23] [24] [25] , antioxidant [26] [27] [28] [29] , antiinflammatory [30] [31] [32] , anti-microbial [23, [33] [34] [35] [36] , anti-tubercular [34, 37, 38] , antileishmanial [39] , antimalarial [40] [41] [42] , anthelmintic [27] , osteogenic activity [43] . This review article focuses on recent applications of Claisen-Schmidt condensation reaction employed in the synthesis of chalcone, its transformation to heterocyclic compounds and pharmacological activities. 
PREPARATION OF CHALCONES
The usual approach to obtain chalcones is through Claisen-Schmidt condensation, several novel heterocyclic chalcone analogs have emerged [23, 43, 44] . Rajkumar and co-workers synthesized 1-hydroxynapthalen-2- 
Mechanism of Claisen-Schmidt's Chalcone Synthesis
Steps in chalcone formation are from first enolization, C−C bond, proton equilibration, second enolization, and hydroxide elimination and C=C bond formation [47] (Scheme 2).
CHALCONES TRANSFORMATION IN HETEROCYCLES SYNTHESIS
Chalcones are useful precursors in producing heterocyclic compounds (Scheme 3).
Meanwhile, Aswin et al. reported pyrimidine-2(1H)-thione 20 from the condensation of chalcone 19 with thiourea using triphenylphosphine (PPh 3 ) as a catalyst [10] . Pyrimidine derivatives 22 were also reported from chalcones 21 with urea in the presence of ethanolic potassium hydroxide solution [11] (Scheme 4).
In another work, Rajaguru Yang et al. studied the reaction of enaminone 37 and tosyl azide to produce NH-1,2,3-triazole 38 [17] . Meanwhile, Wan et al. obtained a series of N-substituted 1,2,3-triazoles 41 from NH-based secondary enaminones 39 and tosyl azide 40 [18] (Scheme 8) .
Scheme 4. Synthesis of pyrimidine from chalcone
Likewise, El-Gaml described the synthesis of [1, 5] 
Scheme 8. Triazoles from chalcones
In another approach, Dou and co-workers synthesized 5-arylisoxazole derivatives 50 from 3-(dimethyl-amino)-1-arylprop-2-en-1-ones 49 treated with hydroxylamine hydrochloride in aqueous media without using any catalyst [7] . Also, chalcone 51 was used to obtain 3,5diphenylisoxazole 52.8 Isoxazole substituted 9anilino acridines 54 were synthesized from some novel chalcone 53 using microwave irradiation [9] (Scheme 10).
Zhang and co-workers reported di-, tri-, and tetrasubstituted (aryl, alkyl, and or vinyl) pyrazoles 57 from readily available α,βunsaturated aldehydes/ketones 55 and hydrazine salts 56 without isolation of the less stable intermediates hydrazones [1] . 
Scheme 12. Synthesis of pyridines from chalcones
In another work, Huang and co-workers produced 2-aryl-substituted pyridines 63 from chalcones 61 with oxime-based 62 [12] . Likewise, di-, tri-, tetra-, and pentasubstituted pyridines, as well as fused pyridines 66, were obtained from chalcones 64 and 2-fluoro-1,3dicarbonyl-initiated 65 in one-pot Michael addition of [ 
PHARMACOLOGICAL ACTIVITIES
Chalcones have broad and multiple pharmacological activities because of the α, βdouble bond, and the presence and the positions of chemical substituents which help in viral disorder, cardiovascular diseases, parasitic infections, pain, gastritis, stomach cancer, cosmetic formulation ingredients. They are useful as anticancer, antidiabetic, anti-inflammatory, and antidiuretic agents.
Antimalarial Activities
Chalcones with inhibitory activity against in vitro Plasmodium parasites provide a useful marker to identify a potential antiplasmodial. Syahri et al. synthesized and evaluated several chalcones for antiplasmodial potential, and found compound 84 actives with an IC 50 (0.59 mM) [40] . In another work, 4-Benzimidazole chalcone 85 was a potent antimalarial agent because of the OCH3 moieties at position two and four in the chalcones [41] . In another paper, chalcone 86 exhibited promising antiplasmodial activities (50% inhibitory concentration [IC 50 ] values 7.45±0.65 and 6.01±0.29 µg/ml, respectively) [42] (Fig. 2 ).
Anti-inflammatory Activities
Rücker and co-workers used electrophilicity of alpha-substituted chalcone analog 87 and 88 (CF3, Br, and Cl) to fine-tune therapeutic effects as potent anti-inflammatory agents in-activating nuclear factor erythroid 2 (NFE2)-related factor 2 (Nrf2) and inhibiting nuclear factor kappa-lightchain-enhancer of activated B cells (NF-κB), with corresponding effects on their respective transcriptional gene products with significant reduction observed in Inducible nitric oxide synthase (iNOS) at a nanomolar range of IC50 values [30] . Debarshi and Ruchi also reported imidazole containing Murrayanine based chalcone 89 as a promising anti-inflammatory agent [31] . Synthetic halo-azachalcones 90 exhibited more significant inhibition [32] (Fig. 3) . 
Anti-microbial Activities
In their paper, Thasneem and co-workers concluded that chalcone 91 with NH 2 and NO 2 showed excellent activity against Staphylococcus aureus (ATCC5922) and Escherichia coli (ATCC6633) respectively whereas OH showed excellent activity against Saccharomyces cerevisiae [33] . In another paper, compounds 92 with substituents H, 2-F, and 2,5-diF displayed activities against the S. aureus, S. pyogenes, E. faecalis, E. coli, and P. aeruginosa while 92 substituent H and compound 93 were active against tested C. albicans [34] . The presence of halogens in chalcone 94 increases microbial susceptibility [35] . Özdemir et al. found compound 95 (4-Cl, 2,5-diCl) significantly active against C. krusei than the reference drug (ketoconazole) in ATP bioluminescence assay, whereas flow cytometry analysis revealed that the percentage of dead cells treated with substituent 4-Cl was more than that treated with 2,5-Cl and ketoconazole. According to Ames MPF assay, compound 95 (4-Cl, 2,5-diCl) was found to be non-genotoxic against TA98 and TA100 with/without metabolic activation [23] . In another work, compound 96 shown similar anticandidal activity to ketoconazole against C. albicans (ATCC 24433), C. krusei (ATCC 6258), C. parapsilosis (ATCC 22019), and C. glabrata (ATCC 90030) and as found potential ergosterol biosynthesis inhibitor [36] ( Fig. 4 ).
Antileishmanial Activity
In another work, compound 97 showed good antileishmanial activity [39] (Fig. 5 ). 
Anti-cancer Activities
In another investigation, Özdemir and co-workers found compound 98 (4-NO 2 and 2-NO 2 ) active and selective on the A549 human lung adenocarcinoma and HepG2 human hepatocellular carcinoma cell line respectively than cisplatin in MTT assay [23] . Meanwhile, compound 99 potently inhibited CYP1B1 with an IC50 (∼0.2 μM) in Sacchrosomes™ and CYP1B1-expressing live human cells [24] . While compound 100 possessed both anti ligase (inhibit human DNA Ligase I) and antiproliferative activity (enhanced cytotoxicity against colon cancer (DLD-1 at IC 50 4.6µM)) [25] (Fig. 6 ).
Anti-Tubercular (TB) Activities
Alam et al. evaluated heterocyclic chalcones 101 for anti-tubercular activity [37] , while, Solankee and Tailor found chalcone 102 to exhibit promising activity [38] , In another work, compound 103 with trimethoxy on ring A and fluoro groups on the B showed enhance activity with IC 50 (≤16,760) against Mycobacterium tuberculosis H37Rv compared to the standard drugs Ethambutol (EMB) and Isoniazid (INH) [34] ( Fig. 7 ).
Osteogenic Activity
In another investigation, compound 104 displayed significant bone matrix mineralization from alkaline phosphatase (ALP) activity and mRNA expressions of osteogenic marker genes (BMP2, RUNX-2, and OCN) at 1 pM concentration [43] (Fig. 8 ).
Anthelmintic Activity
Díaz-Carrillo et al. found out the number and position of hydroxyl substituent in ring B to be responsible for the chalcone antiparasitic activity of chalcones 105 and 106 which at 20 mg/mL was able to kill the parasite at the lesser treatment time about six times lower than the control drug Praziquantel. In conclusion, at least one meta or para hydroxyl group in ring B was adequate for the activity of the synthetic chalcones against H. nana parasite [27] (Fig. 9 ). 
Antioxidant Activity
In another investigation, Lahsasni and coworkers, surprisingly found compound 107 (68.58% at C = 2μg/ml) more effective as an antioxidant agent than the ascorbic acid [26] . Meanwhile, the meta-and para-dihydroxy substitution patterns in ring B of chalcones (catechol structure in ring B) 108 were the best combinations for the highest antioxidant activity compared to caffeic acid (positive control) [27] .
Stepanic et al. found compound 109 potent in 1,1-diphenyl-2-picrylhydrazyl (DPPH•) radical scavenging activity, through single electron transfer followed by a proton transfer (SET-PT) mechanism as revealed by density functional theory (DFT) modeling [28] . Likewise, compound 110 played protective and therapeutic roles against ischemia/reperfusion-related brain injury for both in vitro and in vivo as free radical scavengers or Nuclear factor erythroid 2-related factor 2 (NRF2) pathway stimulators [29] (Fig.  10 ).
CONCLUSION
In summary, chalcones are a real intermediate in the synthesis of heterocyclic compounds, a multifunctional molecule of great pharmacological activities that are usually synthesized via Claisen-Schmidt synthetic method. Chalcones play a functional role in agricultural, medicinal, and industrial chemistry. Therefore, chalcones and their derivatives required further progresses through a modification to achieve more of these unique precursors.
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